During my frequent visits to prescribers’ offices I get a chance to see their prescribing habits. When it comes to DPP-4 inhibitors, medical professionals seem to have similar opinions on how to use each of the drugs from this class. But to test this theory, we contacted 25 primary care …
Read More »Yearly Archives: 2011
VREE — Mobile Application for Diabetes
The Mobile Application for Diabetes from Vree gives your patients a full suite of useful tools and provides Interactive Diabetes Education to supplement the advice you give patients, with extensive learning modules that patients can explore at their own pace. Follow this link to find out more and view a …
Read More »The Role of DPP-IV Inhibitors in the Management of Type 2 Diabetes
In this Special Edition on DPP-IV Inhibitors, we present a set of our Homerun Slides focused on The Role of DPP-IV Inhibitors in the Management of Type 2 Diabetes….
Read More »Role of DPP-4 Inhibitors in Clinical Practice
The dipeptidyl peptidase-4 (DPP-4) inhibitors are a newer class of oral drugs for the treatment of type 2 diabetes. They inhibit the breakdown of glucagon-like peptide-1 (GLP-1) and increase the incretin effect in patients with type 2 diabetes. In clinical practice they are associated with significant reductions in HbA1c, no …
Read More »Editor’s Note: Psychology in Diabetes Care
We often diagnose a patient with diabetes, give them a meter and a prescription and send them on their way. Some of us refer for education or even have an educator in our office but our patients fail no matter what we try. We have learned that there is a …
Read More »Psychology in Diabetes Care, 2nd Ed, Part 1
Foreword to the Second Edition It is difficult to conceive of a disease more likely to cause psychological problems than diabetes.
Read More »Incretins, Part 4 of 7
In this week’s Homerun Slides, we cover DPP-IV inhibitors including a comparison of effects with GLP-1 receptor agonists….
Read More »Letter from the Editor #596: Time to Walk the Walk
How many of you can say you practice what you preach when it comes to food and exercise? How about your office staff, can you say that most of them exemplify the ideals that you promote to patients? Do you think that we have accepted unhealthy food choices, lack of …
Read More »Use of Incretin-Related Medications Will Grow by 47 Percent
A new study found that the incretin-related medications will see the strongest growth among type 2 diabetes drugs over the next nine years.…
Read More »A Culture of Obesity? Time to Walk the Walk
By Sheri Colberg, PhD In updating a chapter on exercise and diabetes for the American College of Sports Medicine, I came across a recently published article about the benefits of lifestyle modification for diabetes prevention. In this study by Djoussé and colleagues at the Brigham and Women’s Hospital …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.